Accretive Health, Inc. 4
4 · Accretive Health, Inc. · Filed Oct 2, 2014
Insider Transaction Report
Form 4
Nayden Denis
Director
Transactions
- Award
Director Stock Option (right to buy)
2014-10-01$3.95/sh+3,793$14,982→ 3,793 totalExercise: $7.90From: 2014-10-01Exp: 2024-10-01→ Common Stock (3,793 underlying)
Footnotes (1)
- [F1]This option was issued to the reporting person pursuant to the Accretive Health director compensation plan in lieu of retainer fees of $15,000.